ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,683,452 | -29.7% | 3,409,446 | -1.2% | 0.00% | -100.0% |
| Q2 2023 | $22,296,030 | -78.4% | 3,451,398 | -74.8% | 0.00% | -66.7% |
| Q1 2023 | $103,254,984 | -26.4% | 13,694,295 | -1.1% | 0.00% | -25.0% |
| Q4 2022 | $140,320,780 | +12.9% | 13,852,002 | +10.2% | 0.00% | 0.0% |
| Q3 2022 | $124,310,000 | -1.3% | 12,569,140 | +6.3% | 0.00% | 0.0% |
| Q2 2022 | $125,940,000 | +427.8% | 11,825,332 | +383.2% | 0.00% | +300.0% |
| Q1 2022 | $23,861,000 | -29.5% | 2,447,299 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $33,852,000 | +73.0% | 2,367,242 | +142.4% | 0.00% | 0.0% |
| Q3 2021 | $19,571,000 | -0.8% | 976,587 | +8.8% | 0.00% | 0.0% |
| Q2 2021 | $19,738,000 | -32.1% | 897,187 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $29,052,000 | +106.0% | 855,473 | +144.1% | 0.00% | – |
| Q4 2020 | $14,102,000 | – | 350,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |